ReviewCancers2026

Towards Predicting Immune-Related Adverse Events: Emerging Biomarkers in Patients Undergoing Immune Checkpoint Inhibitor Therapy.

Nežka Hribernik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.